Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zectivimod by LG Chem for Ulcerative Colitis: Likelihood of Approval
Zectivimod is under clinical development by LG Chem and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase...
Zectivimod by LG Chem for Ulcerative Colitis: Likelihood of Approval
Zectivimod is under clinical development by LG Chem and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase...
LR-20062 by LG Chem for Haemophilus influenzae Type B Infections: Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase I for Haemophilus influenzae Type B Infections. According...
LR-20062 by LG Chem for Diphtheria: Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase I for Diphtheria. According to GlobalData, Phase I...
LR-20062 by LG Chem for Tetanus: Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase I for Tetanus. According to GlobalData, Phase I...
LR-20062 by LG Chem for Poliomyelitis: Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase I for Poliomyelitis. According to GlobalData, Phase I...
LR-20062 by LG Chem for Hepatitis B: Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase I for Hepatitis B. According to GlobalData, Phase...
LR-20062 by LG Chem for Pertussis (Whooping Cough): Likelihood of Approval
LR-20062 is under clinical development by LG Chem and currently in Phase I for Pertussis (Whooping Cough). According to GlobalData,...
LR-19123 by LG Chem for Type 2 Diabetes: Likelihood of Approval
LR-19123 is under clinical development by LG Chem and currently in Phase I for Type 2 Diabetes. According to GlobalData,...
LR-19114 by LG Chem for Hepatitis B: Likelihood of Approval
LR-19114 is under clinical development by LG Chem and currently in Phase III for Hepatitis B. According to GlobalData, Phase...
LR-19114 by LG Chem for Poliomyelitis: Likelihood of Approval
LR-19114 is under clinical development by LG Chem and currently in Phase III for Poliomyelitis. According to GlobalData, Phase III...
LR-19114 by LG Chem for Pertussis (Whooping Cough): Likelihood of Approval
LR-19114 is under clinical development by LG Chem and currently in Phase III for Pertussis (Whooping Cough). According to GlobalData,...
LR-19114 by LG Chem for Tetanus: Likelihood of Approval
LR-19114 is under clinical development by LG Chem and currently in Phase III for Tetanus. According to GlobalData, Phase III...
LR-19114 by LG Chem for Diphtheria: Likelihood of Approval
LR-19114 is under clinical development by LG Chem and currently in Phase III for Diphtheria. According to GlobalData, Phase III...